Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: Large, single-institution, modern cohort study.
Kevin DiaoTheresa P NguyenAmy C MorenoJay P ReddyAdam S GardenCatherine H WangSamuel TungCongjun WangXin A WangDavid I RosenthalClifton David FullerGary B GunnSteven J FrankWilliam H MorrisonShalin J ShahAnna LeeMichael T SpiottoShirley Y SuRenata FerrarottoJack PhanPublished in: Head & neck (2021)
In a large cohort of SBRT reirradiation for recurrent, small volume head and neck cancers, a median OS of 44.3 months was observed. Systemic therapy improved regional and distant control. Toxicities were modulated by anatomic site and systemic therapy.